Skip to main content

Series B Biotechnology Companies

Explore 430 biotechnology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
430
Total Funding
$3.6B
Avg Funding
$142.8M
Cities
19

Export 430 Series B Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Princeton, United States

Illuminare Biotechnologies is a biotechnology company operating intended to reduce nerve damage risk during surgery.

Jul 2026
Series B

Founder Contacts

41,000+ verified contacts

$32.8M
raised

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Breda, The Netherlands
$20.5M
raised

The Protein Brewery specializes in developing and making animal-free-based protein in a sustainable way.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Oakland, United States
$62.0M
raised

Oblenio Bio is a biotechnology company that develops T-cell engager therapeutic candidates for autoimmune disease treatment.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Oakland, United States
$46.0M
raised

xCures is a SaaS platform that aggregates, organizes and structures EMRs providing multimodal data across all diseases.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Francisco, United States
$190.0M
raised

Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$73.8M
raised

Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

$50.0M
raised

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Geleen, The Netherlands
$11.5M
raised

Vertoro transforms woody and agricultural residues into a wide range of bio-based chemicals, materials, and fuels.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

München, Germany
$50.0M
raised

HMNC Brain Health is a precision medicine pioneer in psychiatry based in Munich.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Woburn, United States
$7.3M
raised

Zumutor Biologics develops immuno-oncology therapies that harness the body's innate immune system to treat cancer.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$125.0M
raised

SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Barcelona, Spain
$86.6M
raised

Ona Therapeutics develops antibody-drug conjugates and therapies for the treatment of advanced and treatment-resistant cancers.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Charlottesville, United States
$92.5M
raised

Contraline is a clinical-stage biotechnology company that develops male contraceptive solutions.

Jun 2026
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$5.7M
raised

Elemental Machines delivers data-driven insights that improves R&D, laboratory operations, and manufacturing outcomes.

May 2026
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$122.0M
raised

CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.

May 2026
Series B

Founder Contacts

41,000+ verified contacts

$38.0M
raised

NVision Imaging Technologies develops quantum-based medical imaging technology that enhances the capabilities of standard MRI systems.

May 2026
Series B

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$2.1B
raised

Isomorphic Labs is an AI-first drug design and development company that transforms drug discovery to design and evaluate new medicines.

May 2026
Series B

Founder Contacts

41,000+ verified contacts

Basel, Switzerland
$165.0M
raised

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

May 2026
Series B

Founder Contacts

41,000+ verified contacts

New Haven, United States
$26.5M
raised

Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies to reverse neurodegeneration.

May 2026
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$125.0M
raised

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

Apr 2026
Series B

Founder Contacts

41,000+ verified contacts

Tokyo, Japan
$8.2M
raised

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

Apr 2026
Series B

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$27.0M
raised

Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for inner ear disorders.

Apr 2026
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$100.0M
raised

Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.

Apr 2026
Series B

Founder Contacts

41,000+ verified contacts

Durham, United States
$5.0M
raised

Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.

Apr 2026
Series B

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 430 companies

Ready to Connect with Series B Biotechnology Startups?

Get verified founder emails, funding details, and company data for 430 series b biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked